Findings suggest that identifying children with specific eating behaviors might be a promising approach for targeted intervention to prevent progression eating disorders in adolescence.
Patients may be at risk for increased comorbidity burden after a diagnosis of binge eating disorder.
Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.
Binge eating and purging were found to be common among adolescents and seen at a higher rate in female adolescents.
Delay discounting may be considered a transdiagnostic process across many psychiatric disorders, such as bipolar disorder and borderline personality disorder.
Using virtual reality, investigators found that women with eating disorders paid more attention to weight-related areas of an avatar’s body, while their male counterparts paid more attention to non-weight-related body parts.
The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for dasotraline (Sunovion) in the treatment of binge eating disorder.
Early warning signs may help providers identify eating disorders earlier.
Disordered eating to bulk up is common among young men and may be a warning sign of future health problems.
Women with eating disorders experience persistently greater depressive symptoms across the life-course.
